180 related articles for article (PubMed ID: 17392998)
1. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.
Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998
[No Abstract] [Full Text] [Related]
2. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
3. Coronary heart disease benefits from blood pressure and lipid-lowering.
Sever PS; Poulter NR; Mastorantonakis S; Chang CL; Dahlof B; Wedel H;
Int J Cardiol; 2009 Jun; 135(2):218-22. PubMed ID: 19232755
[TBL] [Abstract][Full Text] [Related]
4. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
5. [Hypertension--does it matter how blood pressure is lowered?].
Mehlsen J
Ugeskr Laeger; 2008 Sep; 170(36):2782-4. PubMed ID: 18761872
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT).
Manisty C; Mayet J; Tapp RJ; Sever PS; Poulter N; McG Thom SA; Hughes AD;
Hypertension; 2009 Nov; 54(5):1009-13. PubMed ID: 19720956
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study.
Aalbers J
Cardiovasc J Afr; 2011; 22(2):101. PubMed ID: 21556456
[No Abstract] [Full Text] [Related]
9. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
[TBL] [Abstract][Full Text] [Related]
10. ASCOT-LLA: questions about the benefits of atorvastatin.
Drummond GA
Lancet; 2003 Jun; 361(9373):1987-8. PubMed ID: 12801765
[No Abstract] [Full Text] [Related]
11. ASCOT-LLA: questions about the benefits of atorvastatin.
Devroey D; Ginst LV
Lancet; 2003 Jun; 361(9373):1985-6; author reply 1986-7. PubMed ID: 12801760
[No Abstract] [Full Text] [Related]
12. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.
Martín-Ventura JL; Tuñon J; Duran MC; Blanco-Colio LM; Vivanco F; Egido J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S189-93. PubMed ID: 17130260
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
Gresser U; Gathof BS
Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
[TBL] [Abstract][Full Text] [Related]
15. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
Li M; Xu A; Lam KS; Cheung BM; Tse HF
Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
[TBL] [Abstract][Full Text] [Related]
16. The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.
Sever PS; Poulter NR; Dahlof B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes G; Mehlsen J; Nieminen MS; O'Brien ET; Ostergren J;
Eur Heart J; 2008 Feb; 29(4):499-508. PubMed ID: 18175773
[TBL] [Abstract][Full Text] [Related]
17. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
Ivanovic B; Tadic M
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
[TBL] [Abstract][Full Text] [Related]
18. Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study.
Nadar S; Lim HS; Beevers DG; Lip GY
J Hum Hypertens; 2002 Dec; 16(12):815-7. PubMed ID: 12522461
[No Abstract] [Full Text] [Related]
19. Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients.
Leibovitz E; Beniashvili M; Zimlichman R; Freiman A; Shargorodsky M; Gavish D
Am J Hypertens; 2003 Sep; 16(9 Pt 1):715-8. PubMed ID: 12944027
[TBL] [Abstract][Full Text] [Related]
20. ASCOT-LLA: questions about the benefits of atorvastatin.
Killestein J
Lancet; 2003 Jun; 361(9373):1986; author reply 1986-7. PubMed ID: 12801762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
